Journal article icon

Journal article

Synthesis and SAR studies of 5-(pyridin-4-yl)-1,3,4-thiadiazol-2-amine derivatives as potent inhibitors of Bloom helicase.

Abstract:
Human cells utilize a variety of complex DNA repair mechanisms in order to combat constant mutagenic and cytotoxic threats from both exogenous and endogenous sources. The RecQ family of DNA helicases, which includes Bloom helicase (BLM), plays an important function in DNA repair by unwinding complementary strands of duplex DNA as well as atypical DNA structures such as Holliday junctions. Mutations of the BLM gene can result in Bloom syndrome, an autosomal recessive disorder associated with cancer predisposition. BLM-deficient cells exhibit increased sensitivity to DNA damaging agents indicating that a selective BLM inhibitor could be useful in potentiating the anticancer activity of these agents. In this work, we describe the medicinal chemistry optimization of the hit molecule following a quantitative high-throughput screen of >355,000 compounds. These efforts lead to the identification of ML216 and related analogs, which possess potent BLM inhibition and exhibit selectivity over related helicases. Moreover, these compounds demonstrated cellular activity by inducing sister chromatid exchanges, a hallmark of Bloom syndrome.
Publication status:
Published

Actions

Access Document

Publisher copy:
10.1016/j.bmcl.2013.08.025

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Structural Genomics Consortium
Role:
Author


Journal:
Bioorganic and medicinal chemistry letters More from this journal
Volume:
23
Issue:
20
Pages:
5660-5666
Publication date:
2013-10-01
DOI:
EISSN:
1464-3405
ISSN:
0960-894X


Language:
English
Keywords:
Pubs id:
pubs:426131
UUID:
uuid:0c462b9a-c6d6-410e-af28-6eaf78cad521
Local pid:
pubs:426131
Source identifiers:
426131
Deposit date:
2013-11-16
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP